Revenue: The sum of all revenue fields included for a company's operating activities.
Alseres Pharmaceuticals Inc. (ALSE) had Revenue of $0.02M for the most recently reported fiscal quarter, ending 2014-06-30.
| Income Statement Financials | |
|
Revenue |
$0.02M |
$-0.32M |
|
-- |
|
$0.02M |
|
$0.34M |
|
$-0.32M |
|
$-0.00M |
|
$-0.32M |
|
$-0.32M |
|
$-0.32M |
|
$-0.32M |
|
$-0.32M |
|
$-0.32M |
|
$-0.32M |
|
$-0.32M |
|
0.01M |
|
0.01M |
|
$-50.00 |
|
$-50.00 |
|
| Balance Sheet Financials | |
$0.22M |
|
-- |
|
$0.06M |
|
$0.28M |
|
$1.81M |
|
$8.30M |
|
$9.85M |
|
$11.66M |
|
$-11.38M |
|
$-11.38M |
|
$-11.38M |
|
0.01M |
|
| Cash Flow Statement Financials | |
$-0.66M |
|
-- |
|
$0.59M |
|
$0.11M |
|
$0.05M |
|
$-0.07M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.12 |
|
-- |
|
-- |
|
-2.69 |
|
-0.74 |
|
100.00% |
|
-1720.50% |
|
-1720.50% |
|
-- |
|
-1741.54% |
|
-1741.54% |
|
$-0.66M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
-- |
|
-- |
|
-- |
|
2.82% |
|
2.82% |
|
-115.04% |
|
10.41% |
|
$-1857.20 |
|
$-107.31 |
|
$-107.31 |
|